Note: Supplemental materials are not guaranteed with Rental or Used book purchases.
Purchase Benefits
What is included with this book?
List of Figures, Tables and Boxes | p. xi |
List of Contributors | p. xiv |
Glossary of Commonly Used Terms | p. xx |
List of Acronyms and Abbreviations | p. xxiv |
Preface | p. xxix |
National Development Priorities and the Role of Institutions: Framing the Issues | |
Introduction: Genetically Modified Crops and National Development Priorities | p. 3 |
Why this book? | p. 3 |
What are genetically modified crops? | p. 4 |
Developing country priorities | p. 6 |
Five policy objectives: Beyond poverty and hunger | p. 6 |
Agenda for global integration and social equity | p. 8 |
Concerns of opposition movements | p. 9 |
Local priorities, local concerns, local processes | p. 11 |
The plan of the book | p. 12 |
Emergence and Global Spread of GM Crops: Explaining the Role of Institutional Change | p. 15 |
History of GM crops: Emergence and global spread | p. 16 |
Research and development | p. 16 |
Commercial production | p. 20 |
Technological innovation and institutional change | p. 24 |
Institutional change for development and diffusion of GM crop varieties | p. 23 |
Why the US leads | p. 26 |
Why Europe diverged | p. 27 |
Why West and Central Africa have not yet adopted the new technology | p. 29 |
Why the crops spread globally to Canada, Argentina, Brazil, China, India and South Africa but not elsewhere | p. 29 |
Alternative institutional models | p. 31 |
US: Leading Science, Technology and Commercialization | p. 36 |
Introduction | p. 36 |
Crop improvement research in the US | p. 36 |
Regulation of GM varieties in the US | p. 36 |
The US seed market | p. 42 |
A model of the transfer of GM technologies to developing countries | p. 46 |
Summary | p. 49 |
Europe: Turning Against Agricultural Biotechnology in the Late 1990s | p. 51 |
Introduction | p. 51 |
Overview: The sequence of policy change from 1980 until 2005 | p. 52 |
Economic interests of stakeholders in Europe | p. 53 |
Support for R&D in biotechnology since the early 1980s and intellectual property rights protection | p. 56 |
Research and development | p. 56 |
Intellectual property rights | p. 58 |
Record of crop approval since early 1990s (including after the 1998-2004 moratorium) | p. 58 |
Regulation: Environmental assessment, labelling, Cartagena Protocol and trade impacts | p. 60 |
Sequence of regulatory moves regarding safety assessments and environmental assessments | p. 60 |
Environment impact assessment: Regulations and politics | p. 61 |
Labelling | p. 61 |
Impact on trade policy and trade flows | p. 62 |
Role in Cartagena Protocol for Biosafety | p. 63 |
A political explanation of the move towards strong precautionary policies | p. 63 |
Future perspectives: Towards new regulations on coexistence? | p. 65 |
West and Central Africa: Strategizing Biotechnology for Food Security and Poverty Reduction | p. 69 |
Introduction | p. 69 |
Biotechnology in the context of national/subregional priorities | p. 71 |
The potential of biotechnology in meeting national priorities | p. 71 |
The constraints | p. 72 |
Embracing the new initiative: Engaging the region | p. 73 |
CORAF/WECARD's approach to agricultural biotechnology research and development in the subregion | p. 73 |
The research and development agenda | p. 74 |
Priority setting process | p. 74 |
The programme | p. 75 |
Product development and delivery focus | p. 76 |
Investments required for agricultural biotechnology in West and Central Africa | p. 78 |
Institutional challenges | p. 79 |
Seed systems | p. 79 |
Intellectual property right issues | p. 81 |
Dual approach to supporting product development and delivery | p. 81 |
Public information and communication for biotechnology | p. 82 |
GM Crops for Development: The Experience of Argentina, Brazil, China, India, South Africa | |
Argentina: Adopting RR Soy, Economic Liberalization, Global Markets and Socio-economic Consequences | p. 85 |
Background | p. 85 |
The diffusion of GM crops | p. 87 |
The seed industry | p. 89 |
Biosafety and other regulations | p. 90 |
Institutional factors in the diffusion of GM crops | p. 91 |
Research and development efforts | p. 94 |
Economic and social impacts | p. 96 |
Distribution of benefits among farmers and input suppliers | p. 96 |
Concluding remarks | p. 99 |
Brazil: Confronting the Challenges of Global Competition and Protecting Biodiversity | p. 104 |
Introduction | p. 104 |
Modern biotechnology research in Brazil: Activities and achievements | p. 105 |
Overview | p. 105 |
Genomic and proteomic research | p. 107 |
Brazilian 'in house' agricultural biotechnology: Some considerations | p. 108 |
Institutional environment | p. 108 |
Research infrastructure and financing | p. 109 |
Training of human resources | p. 110 |
Intellectual property rights and GM crops | p. 110 |
The biosafety law | p. 111 |
Seed companies | p. 113 |
Commercial production of GM crops in Brazil | p. 114 |
Socio-economic issues | p. 116 |
Farm income impact assessments | p. 116 |
Other socio-economic issues | p. 118 |
Identity preservation and market impact | p. 120 |
Conclusion | p. 122 |
China: Emerging Public Sector Model for GM Crop Development | p. 130 |
Introduction | p. 130 |
Agricultural biotechnology development and policy | p. 131 |
Goals and strategies | p. 131 |
Benefits from GM crops | p. 133 |
Development priorities | p. 134 |
Building national capacity in R&D | p. 135 |
Agricultural biotechnology research programmes and institutions | p. 135 |
Agricultural biotechnology research capacity and investment | p. 136 |
Remaining challenges | p. 139 |
Agricultural GM product biosafety regulation | p. 139 |
Institutional setting | p. 139 |
Biosafety regulations | p. 140 |
Remaining challenges | p. 144 |
Commercial dissemination: Policy shifts and impacts | p. 145 |
Intellectual property rights | p. 145 |
The seed industry | p. 147 |
Policy shifts and the impact on producer efficiency | p. 147 |
Identifying the differences in efficiency | p. 148 |
Concluding remarks | p. 149 |
India: Confronting the Challenge - The Potential of Genetically Modified Crops for the Poor | p. 156 |
Introduction | p. 156 |
Poverty reduction and GM crops: The links | p. 157 |
Government policies: Objectives, priorities, commitment | p. 158 |
Public sector research: Agenda and results | p. 159 |
Biotechnology in the private sector | p. 160 |
Biosafety regulation: How has it worked? | p. 161 |
The' illegal' seeds | p. 162 |
Implementation process: Political economy dynamics | p. 163 |
The surplus from Bt cotton: Distribution of gains among farmers, consumers and seed companies | p. 165 |
GM cotton seeds market: Is it competitive? | p. 168 |
Revisiting the impact of GM crops on the poor | p. 170 |
South Africa: Revealing the Potential and Obstacles, the Private Sector Model and Reaching the Traditional Sector | p. 175 |
Introduction | p. 175 |
History and background | p. 176 |
History of agricultural biotechnology and genetically modified crops in South Africa | p. 176 |
Agricultural sector: Dualistic structure and liberalization reforms | p. 178 |
Farm level yield and income impacts for small-scale farmers in South Africa | p. 179 |
Small scale farmers and Bt cotton: Makhatini Flats experience | p. 179 |
Subsistence farmers: Bt maize experience | p. 182 |
R&D in the public and private sectors | p. 183 |
Institutional challenges for R&D | p. 183 |
Policy initiatives to encourage biotechnology R&D | p. 186 |
Biosafety regulation | p. 187 |
Intellectual property rights | p. 188 |
Marketing of seeds and products | p. 189 |
The seed market | p. 189 |
GM free export markets | p. 191 |
Labelling | p. 192 |
Policy challenges and conclusions | p. 193 |
Comparing and Analysing Developing Country Experiences | |
Institutional Changes in Argentina, Brazil, China, India and South Africa | p. 199 |
Commercial production | p. 201 |
Trends: Diffusion outpaces approvals | p. 201 |
Within country differences in diffusion rates | p. 202 |
Institutional factors in diffusion | p. 203 |
Developing R&D capacity | p. 204 |
Outputs | p. 204 |
Scope of investment | p. 213 |
Institutional approaches | p. 214 |
Creating a regulated seed market: Biosafety controls, intellectual property and seed marketing | p. 216 |
Emerging business models for seed development and commercialization | p. 218 |
The Role of Government Policy: For Growth, Sustainability and Equity | p. 222 |
Government policy: Objectives | p. 222 |
Global integration agenda: Technology and markets | p. 223 |
Social equity agendas | p. 225 |
Local contexts: National policy, stakeholders | p. 227 |
Government Policy: Tools | p. 228 |
Support to R&D | p. 230 |
Biosafety legislation | p. 231 |
Patents | p. 232 |
GM crops for poverty reduction and food security: The path not yet taken? | p. 233 |
Index | p. 238 |
Table of Contents provided by Ingram. All Rights Reserved. |
The New copy of this book will include any supplemental materials advertised. Please check the title of the book to determine if it should include any access cards, study guides, lab manuals, CDs, etc.
The Used, Rental and eBook copies of this book are not guaranteed to include any supplemental materials. Typically, only the book itself is included. This is true even if the title states it includes any access cards, study guides, lab manuals, CDs, etc.